Form 4: Life360 Director James Synge Sells Shares on ASX

Director James Synge sold Life360 shares represented by Chess Depositary Interests (CDIs) on the Australian Securities Exchange (ASX).

Summary

• James Synge, a director of Life360, sold shares of the company on March 10, 2025.
• The sales were executed on the Australian Securities Exchange (ASX) through Chess Depositary Interests (CDIs), which represent a 1:3 ratio of common stock to CDI.
• A total of 24,847 shares were sold at a weighted average price of $43.43, with individual transactions ranging from $42.95 to $43.93 per share.
• An additional 153 shares were sold at a weighted average price of $44.04, with individual transactions ranging from $43.95 to $44.07 per share.
• Following these transactions, Synge directly owns 241,944 shares and indirectly owns 3,966 shares through ICCA Labs, LLC.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative. While the transaction itself is routine, director share sales can sometimes raise concerns among investors.

Negatives

• A director selling shares could be perceived negatively by investors.

Risks

• The sale of shares by a director could potentially signal a lack of confidence in the company's future performance.

Industry Context

Directors selling shares is a common occurrence, but the market often scrutinizes these transactions for insights into the director's perspective on the company's valuation and future prospects. It's important to consider the size of the sale relative to the director's total holdings.

Stakeholder Impact

• Shareholders may react to the news of a director selling shares, potentially impacting the stock price.

Key Dates